blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2287163

EP2287163 - 2-AMINO-3-SULPHONYL-TETRAHYDRO-PYRAZOLO[1,5-A]PYRIDO-PYRIMIDINE ANTAGONISTS OF SEROTONIN 5-HT6 RECEPTORS, METHODS FOR THE PRODUCTION AND USE THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  12.06.2015
Database last updated on 05.10.2024
Most recent event   Tooltip22.06.2018Lapse of the patent in a contracting state
New state(s): MK		published on 25.07.2018  [2018/30]
Applicant(s)For all designated states
Ivashchenko, Andrey Alexandrovich
Ul. Abramtsevskaya, 4/2-27
Moscow, 127576 / RU
For all designated states
Alla Chem, LLC.
318 N. Carson Street, Suite 208
Carson City, NV 89701 / US
[2011/08]
Inventor(s)01 / KYSIL, Volodymyr Mikhailovich
ul. Revutskogo 44-436
Kiev 021140 / UA
02 / SAVCHUK, Nikolay Filippovich
ul. Nametkina 9-35
Moscow 117420 / RU
03 / IVASHCHENKO, Alexander Vasilievich
2874 Calle Rancho Vista
Encinitas California 92024 / US
04 / IVASHCHENKO, Andrey Alexandrovich
Ul. Abramtsevskaya, 4/2-27
Moscow, 127576 / RU
 [2014/13]
Former [2011/08]01 / KYSIL, Volodymyr Mikhailovich
ul. Revutskogo 44-436
Kiev 021140 / UA
02 / SAVCHUK, Nikolay Filippovich
ul. Nametkina 9-35
Moscow 117420 / RU
03 / IVASHCHENKO, Alexander Vasilievich
2874 Calle Rancho Vista
Encinitas California 92024 / US
Representative(s)Henrion, Oliver, et al
Patentanwälte Zellentin & Partner Rubensstraße 30
DE-67061 Ludwigshafen / DE
[2011/08]
Application number, filing date09742910.430.04.2009
[2011/08]
WO2009RU00208
Priority number, dateRU2008011784507.05.2008         Original published format: RU 2008117845
[2011/08]
Filing languageRU
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2009136813
Date:12.11.2009
Language:RU
[2009/46]
Type: A1 Application with search report 
No.:EP2287163
Date:23.02.2011
Language:EN
[2011/08]
Type: B1 Patent specification 
No.:EP2287163
Date:06.08.2014
Language:EN
[2014/32]
Search report(s)International search report - published on:RU12.11.2009
(Supplementary) European search report - dispatched on:EP08.02.2012
ClassificationIPC:C07D471/14, A61P25/22, A61K31/519, A61P25/24, A61P25/18, A61P25/28, A61P25/08, A61P3/08, A61P25/26, A61P9/10, A61P25/16, A61P3/04
[2011/08]
CPC:
C07D471/14 (EP,US); A61K31/519 (EP,US); A61P21/00 (EP);
A61P21/02 (EP); A61P25/00 (EP); A61P25/08 (EP);
A61P25/14 (EP); A61P25/16 (EP); A61P25/18 (EP);
A61P25/22 (EP); A61P25/24 (EP); A61P25/26 (EP);
A61P25/28 (EP); A61P25/30 (EP); A61P25/32 (EP);
A61P3/00 (EP); A61P3/04 (EP); A61P3/08 (EP);
A61P3/10 (EP); A61P31/00 (EP); A61P37/00 (EP);
A61P43/00 (EP); A61P5/00 (EP); A61P9/00 (EP);
A61P9/10 (EP) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2011/08]
TitleGerman:2-AMINO-3-SULFONYLTETRAHYDROPYRAZOLO[1,5-A]PYRIDOPYRIMIDINANTAGONISTEN VON SEROTONIN-5-HT6-REZEPTOREN, VERFAHREN ZU DEREN HERSTELLUNG UND DEREN VERWENDUNG[2011/08]
English:2-AMINO-3-SULPHONYL-TETRAHYDRO-PYRAZOLO[1,5-A]PYRIDO-PYRIMIDINE ANTAGONISTS OF SEROTONIN 5-HT6 RECEPTORS, METHODS FOR THE PRODUCTION AND USE THEREOF[2011/08]
French:2-AMINO-3-SULPHONYL-5,6,7,8-TETRAHYDRO-PYRAZOLO[1,5-A]PYRIDO -PYRIMIDINES AGISSANT COMME DES ANTAGONISTES DES RÉCEPTEURS 5-HT6 DE SÉROTONINE ET PROCÉDÉS DE PRODUCTION ET D'UTILIASATION CORRESPONDANTS[2011/08]
Entry into regional phase03.12.2010Translation filed 
07.12.2010National basic fee paid 
07.12.2010Search fee paid 
07.12.2010Designation fee(s) paid 
07.12.2010Examination fee paid 
Examination procedure07.12.2010Examination requested  [2011/08]
06.09.2012Amendment by applicant (claims and/or description)
23.10.2012Despatch of a communication from the examining division (Time limit: M02)
20.12.2012Reply to a communication from the examining division
13.02.2013Communication of intention to grant the patent
18.06.2013Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
28.10.2013Communication of intention to grant the patent
25.02.2014Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
31.03.2014Communication of intention to grant the patent
27.06.2014Fee for grant paid
27.06.2014Fee for publishing/printing paid
27.06.2014Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  23.10.2012
Opposition(s)07.05.2015No opposition filed within time limit [2015/29]
Fees paidRenewal fee
02.05.2011Renewal fee patent year 03
21.03.2012Renewal fee patent year 04
02.05.2013Renewal fee patent year 05
08.03.2014Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU30.04.2009
AT06.08.2014
CY06.08.2014
CZ06.08.2014
EE06.08.2014
ES06.08.2014
FI06.08.2014
HR06.08.2014
IT06.08.2014
LT06.08.2014
LV06.08.2014
MC06.08.2014
MK06.08.2014
MT06.08.2014
NL06.08.2014
PL06.08.2014
RO06.08.2014
SI06.08.2014
SK06.08.2014
TR06.08.2014
BG06.11.2014
NO06.11.2014
GR07.11.2014
IS06.12.2014
PT09.12.2014
IE30.04.2015
LU30.04.2015
[2018/30]
Former [2017/39]HU30.04.2009
AT06.08.2014
CY06.08.2014
CZ06.08.2014
EE06.08.2014
ES06.08.2014
FI06.08.2014
HR06.08.2014
IT06.08.2014
LT06.08.2014
LV06.08.2014
MC06.08.2014
MT06.08.2014
NL06.08.2014
PL06.08.2014
RO06.08.2014
SI06.08.2014
SK06.08.2014
TR06.08.2014
BG06.11.2014
NO06.11.2014
GR07.11.2014
IS06.12.2014
PT09.12.2014
IE30.04.2015
LU30.04.2015
Former [2017/03]AT06.08.2014
CY06.08.2014
CZ06.08.2014
EE06.08.2014
ES06.08.2014
FI06.08.2014
HR06.08.2014
IT06.08.2014
LT06.08.2014
LV06.08.2014
MC06.08.2014
MT06.08.2014
NL06.08.2014
PL06.08.2014
RO06.08.2014
SI06.08.2014
SK06.08.2014
BG06.11.2014
NO06.11.2014
GR07.11.2014
IS06.12.2014
PT09.12.2014
IE30.04.2015
LU30.04.2015
Former [2016/20]AT06.08.2014
CY06.08.2014
CZ06.08.2014
EE06.08.2014
ES06.08.2014
FI06.08.2014
HR06.08.2014
IT06.08.2014
LT06.08.2014
LV06.08.2014
MC06.08.2014
NL06.08.2014
PL06.08.2014
RO06.08.2014
SI06.08.2014
SK06.08.2014
BG06.11.2014
NO06.11.2014
GR07.11.2014
IS06.12.2014
PT09.12.2014
IE30.04.2015
LU30.04.2015
Former [2016/01]AT06.08.2014
CY06.08.2014
CZ06.08.2014
EE06.08.2014
ES06.08.2014
FI06.08.2014
HR06.08.2014
IT06.08.2014
LT06.08.2014
LV06.08.2014
MC06.08.2014
NL06.08.2014
PL06.08.2014
RO06.08.2014
SI06.08.2014
SK06.08.2014
BG06.11.2014
NO06.11.2014
GR07.11.2014
IS06.12.2014
PT09.12.2014
LU30.04.2015
Former [2015/52]AT06.08.2014
CY06.08.2014
CZ06.08.2014
EE06.08.2014
ES06.08.2014
FI06.08.2014
HR06.08.2014
IT06.08.2014
LT06.08.2014
LV06.08.2014
NL06.08.2014
PL06.08.2014
RO06.08.2014
SI06.08.2014
SK06.08.2014
BG06.11.2014
NO06.11.2014
GR07.11.2014
IS06.12.2014
PT09.12.2014
LU30.04.2015
Former [2015/50]AT06.08.2014
CY06.08.2014
CZ06.08.2014
EE06.08.2014
ES06.08.2014
FI06.08.2014
HR06.08.2014
IT06.08.2014
LT06.08.2014
LV06.08.2014
NL06.08.2014
PL06.08.2014
RO06.08.2014
SI06.08.2014
SK06.08.2014
BG06.11.2014
NO06.11.2014
GR07.11.2014
IS06.12.2014
PT09.12.2014
Former [2015/23]AT06.08.2014
CY06.08.2014
CZ06.08.2014
EE06.08.2014
ES06.08.2014
FI06.08.2014
HR06.08.2014
IT06.08.2014
LT06.08.2014
LV06.08.2014
NL06.08.2014
PL06.08.2014
RO06.08.2014
SK06.08.2014
BG06.11.2014
NO06.11.2014
GR07.11.2014
IS06.12.2014
PT09.12.2014
Former [2015/22]AT06.08.2014
CY06.08.2014
ES06.08.2014
FI06.08.2014
HR06.08.2014
IT06.08.2014
LT06.08.2014
LV06.08.2014
NL06.08.2014
PL06.08.2014
RO06.08.2014
BG06.11.2014
NO06.11.2014
GR07.11.2014
IS06.12.2014
PT09.12.2014
Former [2015/12]AT06.08.2014
CY06.08.2014
ES06.08.2014
FI06.08.2014
HR06.08.2014
LT06.08.2014
LV06.08.2014
NL06.08.2014
PL06.08.2014
BG06.11.2014
NO06.11.2014
GR07.11.2014
IS06.12.2014
PT09.12.2014
Former [2015/11]CY06.08.2014
ES06.08.2014
FI06.08.2014
LT06.08.2014
PL06.08.2014
BG06.11.2014
NO06.11.2014
GR07.11.2014
PT09.12.2014
Former [2015/10]ES06.08.2014
FI06.08.2014
LT06.08.2014
BG06.11.2014
NO06.11.2014
Former [2015/09]FI06.08.2014
LT06.08.2014
Former [2015/08]LT06.08.2014
Documents cited:Search   [ ] - No further relevant documents disclosed
International search[A]US4066643  (DENZEL THEODOR, et al);
 [A]US4066645  (DENZEL THEODOR, et al);
 [A]US4072680  (DENZEL THEODOR, et al);
 [A]WO2007147883  (ESTEVE LABOR DR [ES], et al)
by applicantEP0941994
 WO03057674
    - HOLENZ J.; PAUWELS P.J.; DIAZ J.L.; MERCE R.; CODONY X.; BUSCHMANN H., "Medicinal chemistry strategies to 5-HT6 receptor ligands as potential cognitive enhancers and antiobesity agents", DRUG DISC. TODAY., (2006), vol. 11, pages 283 - 299
    - GE'RARD C.; MARTRES M.-P.; LEFE'VRE K.; MIQUEL M.-C.; VERGE' D.; LANFUMEY L.; DOUCET E.; HAMON M.; EL MESTIKAWY S., "Immuno-localisation of serotonin 5-HT6 receptor-like material in the rat central nervous system", BRAIN RESEARCH., (1997), vol. 746, pages 207 - 219
    - DAWSON L.A.; NGUYEN H.Q.; LI P., "The 5-HT(6) receptor antagonist SB-271046 selectively enhances excitatory neurotransmission in the rat frontal cortex and hippocampus", NEUROPSYCHOPHARMACOLOGY., (2001), vol. 25, pages 662 - 668
    - FOLEY A.G.; MURPHY K.J.; HIRST W.D.; GALLAGHER H.C.; HAGAN J.J.; UPTON N.; WALSH F.S.; REGAN C.M., "The 5-HT(6) receptor antagonist SB-271046 reverses scopolamine-disrupted consolidation of a passive avoidance task and ameliorates spatial task deficits in aged rats", NEUROPSYCHOPHARMACOLOGY., (2004), vol. 29, pages 93 - 100
    - RIEMER C.; BORRONI E.; LEVET-TRAFIT B.; MARTIN J.R.; POLI S.; PORTER R.H.; BOS M., "Influence of the 5-HT6 receptor on acetylcholine release in the cortex: pharmacological characterization of 4-(2-bromo-6-pyrrolidin-1-ylpyridine-4-sulfonyl)phenylamine, a potent and selective 5-HT6 receptor antagonist", J MED. CHEM., (2003), vol. 46, pages 1273 - 1276
    - KING M.V.; WOOLLEY M.L.; TOPHAM LA.; SLEIGHT A.J.; MARSDEN C.A.; FONE K.C., "5-HT6 receptor antagonists reverse delay-dependent deficits in novel object discrimination by enhancing consolidation e an effect sensitive to NMDA receptor antagonism", NEUROPHARMACOLOGY, (2004), vol. 47, pages 195 - 204
    - FOLEY A.G.; MURPHY K.J.; HIRST W.D.; GALLAGHER H.C.; HAGAN J.J.; UPTON N.; WALSH F.S.; REGAN C.M., "The 5-HT(6) receptor antagonist SB-271046 reverses scopolamine-disrupted consolidation of a passive avoidance task and ameliorates spatial task deficits in aged rats", NEUROPSYCHOPHARMACOLOGY, (2004), vol. 29, pages 93 - 100
    - VICKER S.P.; DOURISH C.T., "Serotonin receptor ligands and the treatment of obesity", CURR. OPIN. INVESTIG. DRUGS., (2004), vol. 5, pages 377 - 388
    - DAVIES S.L., "Drug discovery targets: 5-HT6 receptor", DRUG FUTURE., (2005), vol. 30, pages 479 - 495
    - WOOLLEY M.L., "5-ht6 receptors", CURR. DRUG TARGETS CNS NEUROL. DISORD., (2004), vol. 3, pages 59 - 79
    - BERGE S.M. ET AL., "Pharmaceutical Salts", J.PHARM.SCI., (1977), vol. 66, pages 1 - 19
    - MONSMA FJ JR; SHEN Y; WARD RP; HAMBLIN MW; SIBLEY DR, "Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs", MOL PHARMACOL., (1993), vol. 43, pages 320 - 327
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.